Product Information
APTENSIO XR 10 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $8.0066 per EA under NDC 42858040145. Its NADAC has been published 87 times since Apr 17, 2024.
FDA first approved this application on Apr 17, 2015. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858040145
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
12/18/2024
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205831FDA Approved
4/17/2015
TE Code
AB3
On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for APTENSIO XR 10 MG CAPSULE has been published 87 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0066 per EA |
|---|---|
| All-time high | $8.0100 (May 15, 2024) |
| All-time low | $7.9970 (Nov 20, 2024) |
| 52-week high | $8.0066 |
| 52-week low | $8.0066 |
| Median price | $8.0066 |
| Average price | $8.0047 |
| Largest weekly change | +0.1% (Dec 18, 2024) |
| Weeks tracked | 87 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
-0.0%
Last surveyed Dec 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of APTENSIO XR 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 10 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $8.0066 per EA (NDC 42858040145), effective Dec 10, 2025.
How has the price of APTENSIO XR 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APTENSIO XR 10 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 87 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for APTENSIO XR 10 MG CAPSULE?
Since Apr 17, 2024, the NADAC for APTENSIO XR 10 MG CAPSULE has ranged from a low of $7.9970 (Nov 20, 2024) to a high of $8.0100 (May 15, 2024), with a median of $8.0066 per EA.
Are there cheaper alternatives to APTENSIO XR 10 MG CAPSULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE CD 10 MG CAP, is $1.2697 per EA — about 84% below APTENSIO XR 10 MG CAPSULE.
Who manufactures APTENSIO XR 10 MG CAPSULE?
APTENSIO XR 10 MG CAPSULE (NDC 42858040145) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.